|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||3.6000 - 3.6000|
|52 Week Range||3.3550 - 7.1150|
|Beta (3Y Monthly)||-0.17|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||0.09 (2.40%)|
|1y Target Est||N/A|
The transaction will be a securitization program sponsored by Nufarm Indústria Química e Farmacêutica S.A. (Nufarm Brasil, not rated), a subsidiary of Nufarm Limited (Nufarm, long-term rating Ba3, global scale, outlook stable). The receivables backing the securities will benefit from a credit insurance policy from Euler Hermes SA (Euler Hermes, long-term rating Aa3, global scale, outlook stable).
Moody's Investors Sevice says that Nufarm Limited's 1H 2019 results are credit negative but its ratings are not affected. "IMPORTANT NOTICE: MOODY'S RATINGS AND PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS. "Nufarm's (Ba3 stable) 1H 2019 results are credit negative, as adjusted EBITDA fell below expectations and an elevated level of working capital has resulted in higher debt", says Maurice O'Connell, a Moody's Vice President and Senior Credit Officer.
Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Nufarm Limited and other ratings that are associated with the same analytical unit. "IMPORTANT NOTICE: MOODY'S RATINGS AND PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS. This publication does not announce a credit rating action and is not an indication of whether or not a credit rating action is likely in the near future.
Moody's Investors Service has today affirmed Nufarm Limited's (Nufarm) corporate family rating of Ba3 and Nufarm Americas Inc.'s and Nufarm Australia Limited's backed senior unsecured ratings of B1. "IMPORTANT NOTICE: MOODY'S RATINGS AND PUBLICATIONS ARE NOT INTENDED FOR USE BY RETAIL INVESTORS.